When exit events , withdrawal due to treatment-emergent adverse events ( TEAEs ) , and withdrawal due to lack of efficacy were summed ( n = 90 ) , the predicted exit percentage ( 32.3 % ; 95 % CI 26.8-37 .8 % ) was also lower than the historical control .